Assessing the Impact of Pharmacist-Initiated versus Provider-Initiated Patient Enrollment in Meds to Bed Services

Purpose: This study evaluated the impact of pharmacist-initiated versus provider-initiated patient enrollment in the Meds to Beds program. The primary objective was to compare the number of high-risk readmission patients enrolled through pharmacist-initiated versus provider-initiated processes. Secondary objectives included comparing 30-day all-cause and heart failure readmission rates, number of prescriptions delivered, patients receiving pharmacist counseling, and impact on HCAHPS scores. Methods: This retrospective, single-center cohort study compared patients in the provider-initiated program (August–October 2023) with those in the pharmacist-initiated program (November 2023–February 2024) at Mount Sinai Brooklyn. Inclusion criteria for the intervention group included patients with COPD, asthma, CHF, ACS, diabetes, hypertension, or age >75. Exclusion criteria included discharges to long-term care facilities and prescriptions for C-II controlled substances. Data analysis included the number of patients being enrolled, counseling numbers, prescribed medications, and readmission rates. Data were sourced from Epic. Descriptive statistics, p-values, and chi-squared testing were used for analysis. Results: A total of 380 patients were enrolled in the pharmacist-initiated group and 162 in the provider-initiated group; 228 and 162 patients received counseling in the respective groups. Of those counseled, 19.7% in the pharmacist-initiated group were readmitted within 30 days, compared to 19.1% in the provider-initiated group. For heart failure patients, 29.6% in the pharmacist-initiated group were readmitted within 30 days, versus 36.4% in the provider-initiated group. HCAHPS scores increased by 15% from Q1 to Q4 2023. The pharmacist-initiated process saw a 26% increase in total medications prescribed. Conclusion: Pharmacists played a pivotal role in enhancing the Meds to Beds process to improve patient outcomes and satisfaction.

Authors

Institutions

Publication Details

Journal
INNOVATIONS in pharmacy
Published
2025-08-08
DOI
https://doi.org/10.24926/iip.v16i2.6378
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessing the Impact of Pharmacist-Initiated versus Provider-Initiated Patient Enrollment in Meds to Bed Services

Tammy Nguyen, A Fain, Shervin Gorji, Alla Melamed Khaytin et al.
INNOVATIONS in pharmacy
Pharmaceutical Practices and Patient Outcomes
article

Assessing the Impact of Pharmacist-Initiated versus Provider-Initiated Patient Enrollment in Meds to Bed Services

Tammy Nguyen, A Fain, Shervin Gorji, Alla Melamed Khaytin, Emily Zoelle, Jordan Denas, Joshua Yaich
article en

Abstract

Purpose: This study evaluated the impact of pharmacist-initiated versus provider-initiated patient enrollment in the Meds to Beds program. The primary objective was to compare the number of high-risk readmission patients enrolled through pharmacist-initiated versus provider-initiated processes. Secondary objectives included comparing 30-day all-cause and heart failure readmission rates, number of prescriptions delivered, patients receiving pharmacist counseling, and impact on HCAHPS scores. Methods: This retrospective, single-center cohort study compared patients in the provider-initiated program (August–October 2023) with those in the pharmacist-initiated program (November 2023–February 2024) at Mount Sinai Brooklyn. Inclusion criteria for the intervention group included patients with COPD, asthma, CHF, ACS, diabetes, hypertension, or age >75. Exclusion criteria included discharges to long-term care facilities and prescriptions for C-II controlled substances. Data analysis included the number of patients being enrolled, counseling numbers, prescribed medications, and readmission rates. Data were sourced from Epic. Descriptive statistics, p-values, and chi-squared testing were used for analysis. Results: A total of 380 patients were enrolled in the pharmacist-initiated group and 162 in the provider-initiated group; 228 and 162 patients received counseling in the respective groups. Of those counseled, 19.7% in the pharmacist-initiated group were readmitted within 30 days, compared to 19.1% in the provider-initiated group. For heart failure patients, 29.6% in the pharmacist-initiated group were readmitted within 30 days, versus 36.4% in the provider-initiated group. HCAHPS scores increased by 15% from Q1 to Q4 2023. The pharmacist-initiated process saw a 26% increase in total medications prescribed. Conclusion: Pharmacists played a pivotal role in enhancing the Meds to Beds process to improve patient outcomes and satisfaction.

INNOVATIONS in pharmacyVol. 16(2)
Mount Sinai Hospital (US), Icahn School of Medicine at Mount Sinai (US)
Quality Education
Openalex Percentile: Top 76%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.